Home › Funds › a16z Capital Management, L.L.C. › RVMD

a16z Capital Management, L.L.C. position in RVMD

REVOLUTION MEDICINES INC · Health Care

a16z Capital Management, L.L.C. reported holding 921,099 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$172.5M, representing 1.21% of its reported portfolio and ranking #3 among its reported holdings. a16z Capital Management, L.L.C. has disclosed RVMD holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)921.10K sh
Reported value held$172.50M
Portfolio Weight1.21%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s RVMD position evolved

a16z Capital Management, L.L.C. first disclosed a stake in RVMD in Q4 2023 at 5,697,067 shares (US$163.4M). The position peaked in Q2 2026 at 921,099 shares, worth US$172.5M. Across 11 filings, a16z Capital Management, L.L.C. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 921,099 shares valued at US$172.5M. Notable position changes include a 52% trim in Q1 2024 (shares rose 20% over the following quarter), a 66% trim in Q4 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 5.70M $163.39M New
Q1 2024 2.75M $88.58M Reduce
Q2 2024 2.75M $106.67M Hold
Q3 2024 2.75M $124.65M Hold
Q4 2024 2.75M $120.22M Hold
Q1 2025 2.75M $97.19M Hold
Q2 2025 2.75M $101.12M Hold
Q3 2025 2.75M $128.36M Hold
Q4 2025 921.10K $73.37M Reduce
Q1 2026 921.10K $89.58M Hold
Q2 2026 921.10K $172.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held RVMD?

a16z Capital Management, L.L.C. has disclosed RVMD holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is a16z Capital Management, L.L.C.'s current position in RVMD?

As of Q2 2026, a16z Capital Management, L.L.C. holds 921.10K shares of RVMD (REVOLUTION MEDICINES INC), valued at $172.50M, representing 1.21% of its reported portfolio and ranking #3.

Has a16z Capital Management, L.L.C. been buying or selling RVMD?

In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in RVMD. The position peaked in Q2 2026 at 921.10K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.